These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design. Vázquez R; García E; García P J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227 [TBL] [Abstract][Full Text] [Related]
4. Bacteriophage-derived endolysins to target gram-negative bacteria. Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins. Gontijo MTP; Vidigal PMP; Lopez MES; Brocchi M Res Microbiol; 2021 Mar; 172(2):103794. PubMed ID: 33347948 [TBL] [Abstract][Full Text] [Related]
6. Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens. Shah S; Das R; Chavan B; Bajpai U; Hanif S; Ahmed S Front Microbiol; 2023; 14():1170418. PubMed ID: 37789862 [TBL] [Abstract][Full Text] [Related]
7. Bacteriophage endolysins as a novel class of antibacterial agents. Borysowski J; Weber-Dabrowska B; Górski A Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432 [TBL] [Abstract][Full Text] [Related]
8. The Advantages and Challenges of Using Endolysins in a Clinical Setting. Murray E; Draper LA; Ross RP; Hill C Viruses; 2021 Apr; 13(4):. PubMed ID: 33920965 [TBL] [Abstract][Full Text] [Related]
9. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials. Vázquez R; García E; García P Front Immunol; 2018; 9():2252. PubMed ID: 30459750 [TBL] [Abstract][Full Text] [Related]
10. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection. Raz A; Serrano A; Hernandez A; Euler CW; Fischetti VA Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010858 [TBL] [Abstract][Full Text] [Related]
11. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens. Fischetti VA Curr Top Microbiol Immunol; 2017; 409():529-540. PubMed ID: 26728063 [TBL] [Abstract][Full Text] [Related]
13. A Novel Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A mSphere; 2017; 2(2):. PubMed ID: 28357414 [TBL] [Abstract][Full Text] [Related]
14. Exploiting what phage have evolved to control gram-positive pathogens. Fischetti VA Bacteriophage; 2011 Jul; 1(4):188-194. PubMed ID: 23050211 [TBL] [Abstract][Full Text] [Related]
17. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria. Heselpoth RD; Euler CW; Schuch R; Fischetti VA Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344 [TBL] [Abstract][Full Text] [Related]
18. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion. Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047 [TBL] [Abstract][Full Text] [Related]
19. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci. Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC Front Microbiol; 2020; 11():574739. PubMed ID: 33324362 [TBL] [Abstract][Full Text] [Related]